tm
Seeing Is Believing
tm
Seeing Is Believing
ATXS is currently covered by 1 analysts
Astria Therapeutics's activity chart (see below) currently has 95 price targets and 86 ratings on display. The stock rating distribution of ATXS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 48.47% with an average time for these price targets to be met of 252.79 days.
Highest price target for ATXS is $13, Lowest price target is $13.
Most recent stock forecast was given by from CANTOR FITZGERALD on 12-Nov-2025. First documented stock forecast 20-Jul-2015.
Currently out of the existing stock ratings of ATXS, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Apr-2025
11 months 8 days ago
(12-Nov-2025)
2/2 (100%)
$42.13 (613.25%)
245
Buy Since 01-Jul-2022
$20
1 years 4 days ago
(16-Oct-2025)
24/24 (100%)
$11.55 (136.69%)
496
Buy Since 03-Mar-2025
$26
1 years 5 days ago
(15-Oct-2025)
4/4 (100%)
$19.13 (278.46%)
303
Buy Since 10-Nov-2021
$13
$-5860.65 (-99.78%)
$28
1 years 5 days ago
(15-Oct-2025)
10/10 (100%)
$1.08 (9.06%)
628
Buy Since 12-May-2017
$28
1 years 7 days ago
(14-Oct-2025)
0/12 (0%)
$17.91 (177.50%)
What is ATXS (Astria Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ATXS (Astria Therapeutics)?
Which analyst has the most public recommendations on ATXS (Astria Therapeutics)?
Which analyst is the currently most bullish on ATXS (Astria Therapeutics)?
Which analyst is the currently most reserved on ATXS (Astria Therapeutics)?
